Your Trusted Partner
503A and 503B Compounding and Pharmacy Malpractice Experts
Our consulting team specializes in navigating complex pharmacy regulations
About healthcareinvesco
Our Mission
At HealthcareInvesco, we are committed to delivering high-quality, expert consulting services tailored to support your law firm, business or institution. Our team is dedicated to providing in-depth knowledge and comprehensive solutions for your most complex compliance, regulatory, and business challenges.
Consulting services
Expert Witness
503B Outsourcing Facilities
503A Compounding Pharmacy
- Pharmacy Standards of Practice
- 503A and 503B Compounding
- Malpractice
- Intellectual Property
- False Claims Act (FCA)
- Anti-Kickback Statute
- Direct to Consumer Advertising
- Consumer Lead Generation
503A Compounding Pharmacy
503B Outsourcing Facilities
503A Compounding Pharmacy
Our consulting experts specialize in solving complex challenges to make your business compliant with federal and state regulations. Our experience can help find the best solution for making your pharmacy successful, safer and complaint.
503B Outsourcing Facilities
503B Outsourcing Facilities
503B Outsourcing Facilities
Our consultants are well versed in addressing a variety of complex federal and state regulatory issues that affect 503B outsourcing facilities.
Hospital Pharmacy
Pharmaceutical Industry
503B Outsourcing Facilities
Our consultants have served leadership roles in hospital pharmacies. They can apply their expertise to systems and processes to improve quality and patient care in your instituion.
Regulatory Remediation
Pharmaceutical Industry
Pharmaceutical Industry
Our consultants have extensive knowledge in FDA, DEA and State board of pharmacy regulations. They can address Form 483 non compliance observations and create system improvements.
Pharmaceutical Industry
Pharmaceutical Industry
Pharmaceutical Industry
Our consultants have served as expert support to the pharmaceutical industry on direct to consumer litigation, Anti-Kickback, False Claims Act, Code of Federal Regulation Prescription Drug Advertising.